Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 548u (MIR548U) is a small, non-coding RNA molecule of ~20–24 nucleotides, part of the primate-specific miR-548 family that regulates gene expression post-transcriptionally, typically by binding to the 3' untranslated regions (UTRs) of target mRNAs and inhibiting their translation or promoting their degradation[3][5][6]. The miR-548 family consists of many members, most of which are poorly conserved, and are believed to have evolved from transposable elements, contributing to genetic diversity in primates[2]. While some miR-548 family members have been implicated in cancer, inflammation, and other biological processes, the specific biological role or therapeutic relevance of MIR548U remains uncharacterized in the literature to date[2][3]. As such, MIR548U has no established role as a therapeutic target, biomarker, or pharmacological target and no safety concerns are currently recognized.
Not established for MIR548U
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 548u (MIR548U).